Eating Attitude in Multiple Sclerosis

Year 2023, Volume: 18 Issue: 2, 60 - 64, 12.07.2023

Yılmaz İnanç , Celaleddin Turgut , Tuğba Kaya

https://doi.org/10.17517/ksutfd.1132269

Abstract

Objective: To examine attitudes to eating in multiple sclerosis (MS) patients.
Materials and Methods: The study included 64 cases diagnosed with MS according to the 2017 McDonald criteria and a control group of 64 healthy volunteers
of similar age, gender, and education level. All the study participants underwent a detailed neurological examination and were then administered the
Eating Attitudes Test (EAT), the Beck Anxiety Inventory (BAI), and the Beck Depreession Inventory (BDI).
Results: In the comparisons between the groups of the EAT results, a score of ≥30 was obtained by 24 (37.5%) MS patients and 14 (21.8%) of the control
group. When the MS patients were compared in two groups according to the Expanded Disability Status Scale (EDSS) score of ≤3 and ≥4, an EAT score of
≥30 was obtained by 11 (25%) patients with EDSS score ≤3 and by 13 (68.5%) patients with EDSS ≥4.
Conclusion: The frequency of eating disorders in the MS patients in this study was found to be higher than the overall frequency in the general population.
This rate reached statistical significance in patients with high EDSS scores. When it is considered that some vitamin and mineral deficiencies are among
the triggers of MS attacks, the presence of eating disorders or poor eating behaviour is important in the follow-up and treatment processes of MS patients.

Keywords

multiple sclerosis, disability, eating attitude

Multipl Sklerozda Yeme Tutumu

Abstract

Amaç: Bu çalışmada Multipl skleroz (MS) hastalarında yeme tutumlarının incelenmesi amaçlanmıştır.
Gereç ve Yöntemler: Bu çalışmaya 2017 McDonald kriterlerine göre MS tanısı olan 64 olgu yanı sıra yaş, cinsiyet ve eğitim düzeyi açısından benzer özellikli
64 sağlıklı gönüllü alındı. Tüm katılımcılara ayrıntılı nörolojik muayene yapılmış olup, yeme tutumu testi, Beck anksiyete ölçeği ve Beck depresyon
ölçeği uygulanmıştır.
Bulgular: Gruplar arasında Yeme Tutum Testi karşılaştırıldığında MS olanlarda YTT≥30 üzerindeki kişi sayısı 24 (%37.5) olduğu, kontrol grubunda bu sayı
14 (%21.8) olup, MS grubunda kontrol grubuna göre yüksek bulunmuştur. MS grubunu EDSS 3 ve altı ile EDSS 4 ve üzeri her iki grubu karşılaştırdığımızda
YTT 30 puan üzeri hasta EDSS 3 ve altında 11 (%25), EDSS 4 ve üzeri 13 (68.5) hasta saptanmıştır. EDSS göre karşılaşıldığında EDSS 4 ve üzeri olan
grupda 30 puan alan hasta oranı daha fazla saptanmıştır.
Sonuç: Çalışmamızda MS hastalarında yeme bozukluğu sıklığı toplumdaki genel sıklığa oranla yüksek bulunmuştur. Bu oran ileri EDSS olan hastalarda
istatiksel olarak daha da anlamlılığa ulaşmıştır. MS hastalarının takiplerinde ve tedavi süreçlerinde atak tetikleyiciler arasında bazı vitamin mineral eksikliği
olduğu da göz önüne alındığında yeme bozuklukları veya bozulmuş yeme davranışının varlığı önem kazanmaktadır.

Keywords

Multipl skleroz, disabilite, yeme tutumu

References

• Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Current opinion in neurology. 2018;31(6):752-759.
• Solaro C, Gamberini G, Masuccio F. G. Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment. CNS drugs. 2018;32(2):117-133.
• Garzon DL, Figgemeier ME. Dying to be thin: identifying and managing eating disorders. Nurse Pract. 2011;36:45-51.
• Fetissov SO, Hallman J, Oreland L, Af Klinteberg B, Grenbäck E, Hulting AL et al. Autoantibodies against alpha–MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc Natl Acad Sci U S A. 2002;99:17155-17160.
• Sekirov I, Russell SL, Antunes LC. M, Finlay BB. Gut microbiota in health and disease. Physiological reviews. 2010;90(3):859-904.
• Hudson JI, Hiripi E, Pope HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;61:348-358.
• Munger KL, Levin, LI, Hollis BW, Howard, NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-2838.
• Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol. 2007;61(6):504-513.
• Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;18:7(1):1759091414568185.
• Boeschoten RE, Braamse AMJ, Beekman ATF Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–341.
• Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol. 2013;6:13-16.
• Moreno-Navarrete JM, Blasco G, Puig J, Biarnés C, Rivero M, Gich J et al. Neuroinflammation in obesity: Circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance. Int J Obes (Lond). 2017;41(11):1627-1635.
• Hedström AK, Olsson T, Alfredsson L. Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler. 2016;22(7):878-883.
• Boeschoten R. E, Braamse A, Beekman A, Cuijpers P, van Oppen P. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. Journal of the neurological sciences. 2017;372:331–341.
• Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet (London, England). 2007;370(9590):851–858.
• Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of Multiple Sclerosis: State of the Art. Psychiatry investigation. 2019;16(12):877–888.